Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Fuller Smith & Turner Gets GBP100 Million

Mon, 01st Jun 2020 11:16

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Fuller Smith & Turner PLC - pubs - To issue commercial paper under Covid Corporate Financing facility for initial sum of GBP100 million, allowing GBP155 million revolving credit facility to remain undrawn. Placed 96% of employees on furlough, while executives and board members volunteered for pay reduction.

----------

Arricano Real Estate PLC - property - All five shopping centres in Ukraine open with effect on Saturday last week, as restrictions by local authorities on access to shopping centres lifted. However, food courts, cinema and entertainment centres will remain closed.

----------

Topps Tiles PLC - tile retail - To sale and leaseback head office in Enderby, Leicester, to UK Warehouse Properties Ltd for GBP18.1 million. Proceeds expected to strengthen group's financial position in the face of the Covid-19 crisis.

----------

Mattioli Woods PLC - wealth management - Annual revenue to be ahead of GBP58.5 million reported the year before. Profit to be ahead of management expectations. Directors to take 50% reduction in salaries and fees until end of June, while chief executive officer takes no salary at all. Group in strong financial position following the acquisition of Hurley Partners in March.

----------

Motif Bio PLC - cash shell - Remains in negotiations with several reverse takeover candidates in the healthcare sector, as the pandemic creates new opportunities for healthcare firms.

----------

CloudCall Group PLC - communications - Expects to have enough cash to fund it through period of macroeconomic uncertainty. Continues to report ongoing challenges within the broader marketplace, which has near-term impact on the sales pipeline. Year-to-date sales bookings from new customers 28% less than same period the year before.

----------

Zoetic International PLC - cannabidiol - Signs distribution agreement with partner BettermentRS to market tobacco-alternative Chill products to its network of outlets. Rollout of Chill brand delayed by pandemic, as many retail outlets closed on lockdown restrictions.

----------

MJ Hudson Group PLC - asset management - Reports strong sales activity and levels of client work during lockdown period. Confident in achieving profit for year ending June 30 in line with market expectations, despite revenue disruption due to the lack of new fund launch activity.

----------

Marshall Motor Holdings PLC - cars - Trading significantly ahead of UK market in first quarter of 2020. As lockdown eases, group gradually expanded its offering of aftersales services, with initial demand encouraging. Furloughed 90% of employees during lockdown period as many stores closed. To post a pretax loss for the first half of 2020.

----------

Braveheart Investment Group PLC - investments - Subsidiary Paraytec Ltd to launch project with University of Sheffield to develop a rapid test for Covid-19 test, which will utilise highly sensitive light-based detection system coupled with a molecular "affinity" device to capture Covid-19 virus particles. Paraytec to own all foreground intellectual property generated by the project.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Jul 2018 10:47

Motif Bio Director Robert Bertoldi To Resign From Role July 16

LONDON (Alliance News) - Clinical-stage biopharmaceutical company Motif Bio PLC said Tuesday that Director Robert Bertoldi will resign from the board with effect on July 16.Chief Executive

Read more
23 May 2018 14:39

Amphion Sells 8.9 Million Shares In Motif Bio To Repay Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said on Wednesday it sold 8.9 million shares in partner company Motif Bio PLC to partially repay a loan facility, as well as to fund ongoing &

Read more
17 May 2018 14:56

UPDATE: Motif Bio Completes GBP10 Million Fundraise Through Placing (ALLISS)

LONDON (Alliance News) - Biopharmaceutical firm Motif Bio PLC said it has successfully raised GBP10 million via an accelerated bookbuild exercise on Thursday.The company placed 32.3 million

Read more
17 May 2018 12:20

Motif Bio To Raise GBP10 Million Via Accelerated Share Bookbuild (ALLISS)

LONDON (Alliance News) - Motif Bio PLC said it plans to raise GBP10 million via an accelerated bookbuild exercise, which will launch on Thursday.The funds raised will be used by the company

Read more
19 Apr 2018 13:59

Motif Bio's Iclaprim Delivers Continued Good Test Results

LONDON (Alliance News) - Motif Bio PLC on Thursday said iclaprim delivered further positive results as part of its REVIVE-2 phase three trial.Motif Bio previously had said iclaprim showed a

Read more
20 Mar 2018 11:08

Motif Bio Delays Iclaprim New Drug Application, Shares Fall

LONDON (Alliance News) - Motif Bio PLC's shares fell on Tuesday as the biopharmaceutical company said it has pushed back the date for its new drug application submission a

Read more
7 Mar 2018 13:24

Motif Bio Issues 178,571 Shares Following Warrants Exercise (ALLISS)

LONDON (Alliance News) - Motif Bio PLC said Wednesday it has raised GBP57,499 through the issue of 178,571 shares at a price of 32.2 pence per of

Read more
31 Oct 2016 10:58

Motif Bio may need to raise cash as antibiotic trial accelerates

(ShareCast News) - As it prepares to list on the Nasdaq, AIM-listed antibiotics developer Motif Bio said it was likely to need extra funding as enrolments for its latest clinical trial were going faster than expected. Patient enrolment in Motif's Revive 1 phase-three trial has exceeded projections a

Read more
9 Aug 2016 09:43

WINNERS & LOSERS SUMMARY: Worldpay Bid Up After Strong First Half

Read more
13 Jul 2016 09:43

WINNERS & LOSERS SUMMARY: Poundland Jumps On Steinhoff Takeover Deal

Read more
13 Jul 2016 08:13

Motif Bio Shares Rise As It Files To List On NASDAQ Market (ALLIPO)

Read more
23 Jun 2016 09:01

Amphion Reports Huge Net Asset Value Rise Thanks To Motif Bio

Read more
28 Apr 2016 09:01

Amphion Innovations To Draw Debt To Repay Existing Borrowings

Read more
20 Apr 2016 07:31

Motif Bio Loss Widens In 2015 As It Continues Iclaprim Progression

Read more
14 Apr 2016 07:52

Motif Bio Appoints New Chief Financial Officer, Clinical Operations VP

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.